- Home
- ATAI vs RERE Comparison
ATAI vs RERE Comparison
Compare ATAI & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- RERE
- Stock Information
- Founded
- ATAI 2018
- RERE 2011
- Country
- ATAI Netherlands
- RERE China
- Employees
- ATAI N/A
- RERE 2109
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- ATAI Health Care
- RERE Consumer Discretionary
- Exchange
- ATAI Nasdaq
- RERE Nasdaq
- Market Cap
- ATAI 1.1B
- RERE 859.3M
- IPO Year
- ATAI 2021
- RERE 2021
- Fundamental
- Price
- ATAI $5.84
- RERE $3.87
- Analyst Decision
- ATAI Strong Buy
- RERE
- Analyst Count
- ATAI 5
- RERE 0
- Target Price
- ATAI $14.00
- RERE N/A
- AVG Volume (30 Days)
- ATAI 7.0M
- RERE 1.6M
- Earning Date
- ATAI 11-14-2025
- RERE 11-19-2025
- Dividend Yield
- ATAI N/A
- RERE N/A
- EPS Growth
- ATAI N/A
- RERE N/A
- EPS
- ATAI N/A
- RERE 0.12
- Revenue
- ATAI $2,309,000.00
- RERE $2,588,775,650.00
- Revenue This Year
- ATAI $736.04
- RERE $30.66
- Revenue Next Year
- ATAI N/A
- RERE $25.12
- P/E Ratio
- ATAI N/A
- RERE $31.76
- Revenue Growth
- ATAI 510.85
- RERE 27.39
- 52 Week Low
- ATAI $1.04
- RERE $2.00
- 52 Week High
- ATAI $6.75
- RERE $4.93
- Technical
- Relative Strength Index (RSI)
- ATAI 54.11
- RERE 42.25
- Support Level
- ATAI $5.50
- RERE $3.66
- Resistance Level
- ATAI $6.23
- RERE $4.35
- Average True Range (ATR)
- ATAI 0.47
- RERE 0.20
- MACD
- ATAI -0.05
- RERE -0.02
- Stochastic Oscillator
- ATAI 36.10
- RERE 30.43
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.